Brief: Clinical Laserthermia Systems Announces Initiation Of Prostate Cancer Clinical Study
07/11/2023 12:27
Nov 7 (Reuters) - Clinical Laserthermia Systems AB
CLSRb.ST :
* CLINICAL LASERTHERMIA SYSTEMS ANNOUNCES INITIATION OF
PROSTATE
CANCER CLINICAL STUDY IN COLLABORATION WITH U.S BASED HALO
DIAGNOSTICS
* US SUBSIDIARY CLS AMERICAS AND US BASED HALO DIAGNOSTICS
HAS
ENTERED AGREEMENT TO INITIATE CLINICAL STUDY
Source text for Eikon: ID:nWkr3LjDdM
Further company coverage: CLSRb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: Clinical Laserthermia Systems AB Resolves On A Directed Issue
Brief: Clinical Laserthermia Appoints Katarina Lundqvist As Permanent CFO
Brief: CLS Announces Outcome In Rights Issue Of Units
Brief: CLS Agrees On Top-Down Guarantee For Rights Issue
Brief: CLS Conducts Rights Issue Of SEK 39.5 Million